Biotechnology Institute of the Czech Academy of Sciences
By 1st January 2008, the Academy of Sciences of the Czech Republic (AS CR) established a new public research institution, the Institute of Biotechnology AS CR, v.v.i. at its biomedical research campus in Prague-Krč.
The primary ambition of this new institute is to develop cutting-edge basic and oriented research on topics opening for diagnostic and therapeutic applications in human medicine. In particular, the institute was established to serve as a nucleation center of BIOCEV, the planned joined Biotech&Biomed Research Center of the Academy of Sciences with Charles University, to be built at Vestec near Prague by the year 2012 with the support of the European Regional Development Funds in frame of the Operational Program R&D for Innovation.
Having arisen by a transformation of the Division of Biotechnology of the Institute of Molecular Genetics AS CR, v.v.i. into an independent legal body, the new institute of 45 employees currently consists of 6 established research groups.
The department of gene expression at the Institute of Biotechnology is the leading laboratory in Europe on expression profiling by real-time PCR. Its experience ranges from sample collection, calibration and data analysis. In collaboration with TATAA Biocenter, researchers pioneered single cell expression profiling and later multivariate and multiway expression profiling.